Catheter Precision (VTAK) Amortization of Goodwill (2023)

Catheter Precision (VTAK) reported Amortization of Goodwill of -$34000.0 for Q4 2023, down 100.7% quarter-over-quarter from $4.8 million in Q2 2023.

Catheter Precision (VTAK) Amortization of Goodwill (2023) Analysis & Trends

Catheter Precision (VTAK) has 1 years of Amortization of Goodwill data on file, last reported at -$34000.0 in Q4 2023.

Amortization of Goodwill for Q4 2023 came in at -$34000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was -$34000.0 (down 100.06% YoY), and the FY2023 annual result was $60.9 million, changed N/A from the prior year.
Amortization of Goodwill declined to -$34000.0 in Q4 2023 per VTAK's latest filing, from $4.8 million in the prior quarter.
Over five years, Amortization of Goodwill peaked at $56.1 million in Q1 2023 and troughed at -$34000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Catheter Precision	921,210.28	109,210.28	390,000.00

Download Data